AblaSure - Driven by AI

Side by side comparison of pre- and postoperative images has shown to produce poor outcomes. Evaluation of treatment success by assessment of ablation margins remains difficult and is subject to misjudgment in up to 44% of cases¹. Hence, a crucial point in curative treatments of HCC is the evaluation of treatment success by utilizing specific software functionalites^2,3. AblaSure is an AI trained on large data sets enabling instantaneous, seamless and three-dimensional assessment of effective ablation margins against the previously created treatment plan. This AI-driven algorithm additionally calculates the percentage of coverage indicating the extent to which the tumor and planned margin has been ablated.